Qinlock is a cancer medicine used to treat gastrointestinal stromal tumour (GIST), a cancer of the stomach and bowel, in adults with advanced disease who have already been treated with three or more medicines of the \u2018kinase inhibitor\u2019 class, including a medicine called imatinib.<\/p>\n
GIST is rare, and Qinlock was designated an \u2018orphan medicine<\/a>\u2019 (a medicine used in rare diseases) on 12 October 2017.\u00a0Qinlock contains the\u00a0active substance<\/a>\u00a0ripretinib.<\/p>\n To access ripretinib tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n Qinlock is a medication used for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST), who have received different types of treatment with 3 or more kinase inhibitors, including imatinib, sunitinib and regorafenib.<\/p>\n Facts about ripretinib tablets<\/strong><\/p>\n Disease Indications-Gastric Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import “ripretinib tablets\u201d based on the information you provide.<\/strong><\/p>\nHow can 1 go about obtaining ripretinib tablets?<\/h3>\n
QINLOCK (ripretinib) tablets, for oral use Initial U.S. Approval: 2020<\/h5>\n","protected":false},"excerpt":{"rendered":"
ripretinib tablets,
\nfor oral use Initial U.S. Approval: 2020<\/h2>\n
\nManufacturer-Deciphera Pharmaceuticals, Inc.
\nUsage-Oral
\nMedicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n